Log In
Print
BCIQ
Print
Print this Print this
 

GI-3000

  Manage Alerts
Collapse Summary General Information
Company GlobeImmune Inc.
DescriptionWhole heat-killed recombinant Saccharomyces cerevisiae genetically engineered (Tarmogen) to express epidermal growth factor receptor.
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionBinds epidermal growth factor (EGF) receptor
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat EGFR tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today